echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Oncogene: DCAF12 is a novel antagonist of anti-apoptotic protein IAPs

    Oncogene: DCAF12 is a novel antagonist of anti-apoptotic protein IAPs

    • Last Update: 2022-05-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    <>


    Associate Researcher Wang Chenji of Fudan University and Professor Li Liang of Zibo Central Hospital jointly published a paper titled " DCAF12 promotes apoptosis and inhibits NF-κB activation by acting as an endogenous antagonist of " Oncogene Magazine on April 22 , 2022 .



     Apoptosis or programmed cell death is an evolutionarily conserved process that is required for normal development, homeostasis and integrity of multicellular organisms


     DCAF12 is a substrate-recognition subunit of the Cullin 4 ( CUL4 ) E3 ubiquitin ligase complex


    Molecular mechanism of DCAF12- dependent regulation of apoptosis by IAPs


    Jiao Dongyue and Chen Yingji, doctoral students of the School of Life Sciences of Fudan University, are the co-first authors of the paper, and Associate Researcher Wang Chenji and Professor Li Liang of Zibo Central Hospital are the co-corresponding authors of the paper



    Original link: https:// class="western" >






    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.